Skip to main content

Table 1 Histologic subtype of ovarian cancer patients who visited the HCP for BRCA mutation testing before and after the educational campaign

From: A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention

 

BRCA mutation tested (n = 887)

BRCA positive (n = 163)

Histologic subtype, n (%)

Before the campaign

After the campaign

Total

Before the campaign

After the campaign

Total

Serous

270 (59.0)

311 (72.5)

581 (65.5)

76 (73.8)

48 (79.7)

124 (75.6)

Endometrioid

60 (13.1)

29 (6.8)

89 (10.0)

5 (4.9)

< 3% a

< 5%a

Clear cell

31 (6.8)

15 (3.5)

46 (5.2)

< 4%a

< 3%a

< 5%a

Unknown

95 (20.7)

71 (16.6)

166 (18.7)

19 (18.5)

10 (16.4)

29 (17.7)

p-value

  

< 0.001

  

0.519

  1. aSuppressed due to small cell sizes so approximate percentages have been reported Mucinous cancer was excluded from this table due to privacy concerns around small cell sizes
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us